Literature DB >> 28609714

MFHAS1 suppresses TLR4 signaling pathway via induction of PP2A C subunit cytoplasm translocation and inhibition of c-Jun dephosphorylation at Thr239.

Qiqing Shi1, Bo Xiong2, Jing Zhong2, Huihui Wang2, Duan Ma3, Changhong Miao4.   

Abstract

TLR4, an important Toll-like receptor in innate immunity, can be activated by LPS and induce proinflammatory cytokines to resist invasion of pathogenic microorganism, but excessive inflammation can trigger tissue injury. Many genes negatively regulate TLR4 signaling pathway. Recent studies found that malignant fibrous histiocytoma amplified sequence 1 (MFHAS1) suppressed the expression of cytokine IL6 in Raw264.7 cells stimulated by LPS, but the mechanisms remained unclear. This study investigated the role of MFHAS1 in TLR4 signaling pathway and the possible mechanisms implicated. The results indicated that the expression of MFHAS1 was significantly increased in cells stimulated with LPS. Up-regulation of MFHAS1 effectively suppressed inflammatory cytokine expression in cells exposed to LPS, whereas down-regulation of MFHAS1 markedly increased inflammatory cytokines expression. Co-immunoprecipitation, pull-down and immunofluorescence tests demonstrated that MFHAS1 combined with the B and C subunits of PP2A and induced cytoplasm translocation of the C subunit, leading to decrease dephosphorylation of c-Jun at Thr239 and increase degradation of c-Jun. Reduction of c-Jun protein results in decreased AP-1 activity, which is independent of inhibition of JNK or p38MAPK phosphorylation. Taken together, these results indicate that MFHAS1 suppresses TLR4 signaling pathway through induction of PP2A C subunit cytoplasm translocation and subsequent c-Jun degradation, leading finally to decrease AP-1 activity and cytokines expression.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AP-1; LPS; MFHAS1; PP2A; TLR4 signaling pathway; c-Jun

Mesh:

Substances:

Year:  2017        PMID: 28609714     DOI: 10.1016/j.molimm.2017.06.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Paralogues From the Expanded Tlr11 Gene Family in Mudskipper (Boleophthalmus pectinirostris) Are Under Positive Selection and Respond Differently to LPS/Poly(I:C) Challenge.

Authors:  Heng Tong Qiu; Jorge M O Fernandes; Wan Shu Hong; Hai Xu Wu; Yu Ting Zhang; Sheng Huang; Dong Teng Liu; Hui Yu; Qiong Wang; Xin Xin You; Shi Xi Chen
Journal:  Front Immunol       Date:  2019-02-28       Impact factor: 7.561

Review 2.  Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration.

Authors:  Andrew R Clark; Michael Ohlmeyer
Journal:  Pharmacol Ther       Date:  2019-06-01       Impact factor: 12.310

3.  Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4.

Authors:  Huan Lian; Yi Cheng; Xiaoyan Wu
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

Review 4.  Phosphatases in toll-like receptors signaling: the unfairly-forgotten.

Authors:  Valérie Lannoy; Anthony Côté-Biron; Claude Asselin; Nathalie Rivard
Journal:  Cell Commun Signal       Date:  2021-01-25       Impact factor: 5.712

5.  An epigenome-wide view of osteoarthritis in primary tissues.

Authors:  Peter Kreitmaier; Matthew Suderman; Lorraine Southam; Rodrigo Coutinho de Almeida; Konstantinos Hatzikotoulas; Ingrid Meulenbelt; Julia Steinberg; Caroline L Relton; J Mark Wilkinson; Eleftheria Zeggini
Journal:  Am J Hum Genet       Date:  2022-06-08       Impact factor: 11.043

6.  New pentadienone oxime ester derivatives: synthesis and anti-inflammatory activity.

Authors:  Qin Li; Juping Zhang; Liu Zeng Chen; Jie Quan Wang; Hai Ping Zhou; Wen Jian Tang; Wei Xue; Xin Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.